triiodothyronine has been researched along with Metabolic Diseases in 19 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overweight/obesity mediated the associations of MAFLD with triiodothyronine (T3), free triiodothyronine (FT3), free thyroxine (FT4), and the mediator accounted for 46." | 4.31 | The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. ( Cao, L; Chen, X; Fan, H; Li, L; Liu, Z; Suo, C; Zhang, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (73.68) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H | 1 |
| Li, L | 1 |
| Liu, Z | 1 |
| Cao, L | 1 |
| Chen, X | 1 |
| Suo, C | 1 |
| Zhang, T | 1 |
| Zhao, Y | 1 |
| Xue, Q | 1 |
| Su, X | 1 |
| Xie, L | 1 |
| Yan, Y | 1 |
| Steinman, AD | 1 |
| Finan, B | 1 |
| Clemmensen, C | 1 |
| Zhu, Z | 1 |
| Stemmer, K | 1 |
| Gauthier, K | 1 |
| Müller, L | 1 |
| De Angelis, M | 1 |
| Moreth, K | 1 |
| Neff, F | 1 |
| Perez-Tilve, D | 1 |
| Fischer, K | 1 |
| Lutter, D | 1 |
| Sánchez-Garrido, MA | 1 |
| Liu, P | 1 |
| Tuckermann, J | 1 |
| Malehmir, M | 1 |
| Healy, ME | 1 |
| Weber, A | 1 |
| Heikenwalder, M | 1 |
| Jastroch, M | 1 |
| Kleinert, M | 1 |
| Jall, S | 1 |
| Brandt, S | 1 |
| Flamant, F | 1 |
| Schramm, KW | 1 |
| Biebermann, H | 1 |
| Döring, Y | 1 |
| Weber, C | 1 |
| Habegger, KM | 1 |
| Keuper, M | 1 |
| Gelfanov, V | 1 |
| Liu, F | 1 |
| Köhrle, J | 1 |
| Rozman, J | 1 |
| Fuchs, H | 1 |
| Gailus-Durner, V | 1 |
| Hrabě de Angelis, M | 1 |
| Hofmann, SM | 1 |
| Yang, B | 1 |
| Tschöp, MH | 1 |
| DiMarchi, R | 1 |
| Müller, TD | 1 |
| Kim, SR | 1 |
| Tull, ES | 1 |
| Talbott, EO | 1 |
| Vogt, MT | 1 |
| Kuller, LH | 1 |
| HELM, AH | 2 |
| HORTLING, H | 1 |
| LATVALAHTI, J | 1 |
| MORTON, JH | 1 |
| LEVIN, ME | 1 |
| CHIVU, V | 1 |
| STANCU, H | 1 |
| MOLNAR, GD | 1 |
| COLBY, MY | 1 |
| WOOLNER, LB | 1 |
| VANNOTTI, A | 1 |
| LEMARCHAND BERAUD, T | 1 |
| SCAZZIGA, BR | 1 |
| LAMBUSIER, P | 1 |
| QUINTARD, J | 1 |
| GODLOWSKI, ZZ | 1 |
| Gonzales, E | 1 |
| Buyse, J | 1 |
| Sartori, JR | 1 |
| Loddi, MM | 1 |
| Decuypere, E | 1 |
| Gerok, W | 1 |
| Reinwein, D | 1 |
| Hackenberg, K | 1 |
| Gharib, H | 1 |
| Munoz, JM | 1 |
| Wilson, WR | 1 |
| Theilen, EO | 1 |
| Hege, JH | 1 |
| Valenca, MR | 1 |
| Tezuka, U | 1 |
| Murakami, T | 1 |
| Mishiro, K | 1 |
| Fujino, M | 1 |
| Takeichi, O | 1 |
1 review available for triiodothyronine and Metabolic Diseases
| Article | Year |
|---|---|
[Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].
Topics: Adult; Binding Sites; Cell Membrane; Child; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type | 1979 |
18 other studies available for triiodothyronine and Metabolic Diseases
| Article | Year |
|---|---|
The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes.
Topics: Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thyroid Hormones | 2023 |
Microcystin-LR induced thyroid dysfunction and metabolic disorders in mice.
Topics: Animals; Behavior, Animal; Biomarkers; Blood Glucose; Dose-Response Relationship, Drug; Eating; Endo | 2015 |
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Topics: Animals; Atherosclerosis; Body Weight; Bone and Bones; Chemical Engineering; Cholesterol; Diabetes M | 2016 |
A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis.
Topics: GTP-Binding Proteins; Homeostasis; Humans; Insulin; Insulin Resistance; Metabolic Diseases; Models, | 2002 |
Value of a therapeutic trial with liothyronine.
Topics: Humans; Metabolic Diseases; Triiodothyronine | 1957 |
Value of a therapeutic trial with liothyronine.
Topics: Humans; Metabolic Diseases; Triiodothyronine | 1957 |
Value of a therapeutic trial with liothyronine.
Topics: Humans; Metabolic Diseases; Triiodothyronine | 1957 |
Value of a therapeutic trial with liothyronine.
Topics: Humans; Metabolic Diseases; Triiodothyronine | 1957 |
Effect of short-term administration of l'-triiodothyronine in hypometabolism.
Topics: Metabolic Diseases; Triiodothyronine | 1957 |
Sodium liothyronine in metabolic insufficiency syndrome and associated disorders; preliminary report.
Topics: Diagnosis, Differential; Humans; Hypothyroidism; Metabolic Diseases; Metabolic Syndrome; Sodium; Tri | 1957 |
"Metabolic insufficiency": a double-blind study using triiodothyronine, thyroxine and a placebo: psychometric evaluation of the hypometabolic patient.
Topics: Double-Blind Method; Humans; Metabolic Diseases; Psychometrics; Thyroxine; Triiodothyronine | 1960 |
[The effect of triiodothyronine on the cortisol utilization curve in patients with Addison's disease].
Topics: Addison Disease; Adrenal Insufficiency; Humans; Hydrocortisone; Hypoadrenocorticism, Familial; Lipid | 1962 |
CLINICS ON ENDOCRINE AND METABOLIC DISEASES. 11. DEMONSTRATION OF THYROID-STIMULATING-HORMONE DEPENDENCE IN A CASE OF METASTATIC CARCINOMA OF THYROID ORIGIN.
Topics: Bone Marrow Examination; Carcinoma; Humans; Iodine Isotopes; Metabolic Diseases; Neoplasm Metastasis | 1963 |
[PLASMATIC IODINATED PRODUCTS IN THYROID DISEASES].
Topics: Autoradiography; Blood Chemical Analysis; Chromatography; Diiodotyrosine; Goiter; Humans; Hyperthyro | 1964 |
[Sodium liothyronine and hypometabolic syndromes].
Topics: Humans; Metabolic Diseases; Sodium; Syndrome; Triiodothyronine | 1962 |
ALLERGY IS A METABOLIC DISEASE.
Topics: Adrenal Cortex Hormones; Antigen-Antibody Reactions; Enzyme Inhibitors; Enzymes; Humans; Hypersensit | 1964 |
Metabolic disturbances in male broilers of different strains. 2. Relationship between the thyroid and somatotropic axes with growth rate and mortality.
Topics: Aging; Animals; Chickens; Death; Growth Hormone; Insulin-Like Growth Factor I; Male; Metabolic Disea | 1999 |
[Euthyroid goiter with iodination defect and predominant formation of triiodothyronine, as a new form of iodine malutiligation].
Topics: Adult; Diagnosis, Differential; Diiodotyrosine; Female; Goiter; Goiter, Nodular; Humans; Iodine; Iod | 1970 |
Endocrine manifestations of diphenylhydantoin therapy.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Alkaline Phosphatase; Blood Glucose; End | 1974 |
Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.
Topics: Adult; Blood Pressure; Cardiac Output; Heart Rate; Humans; Hyperthyroidism; Isoproterenol; Male; Met | 1966 |
Congenital goiter found in a district of Omuro, Kochi, Shikoku, Japan: familial goiter caused by possible defect of diiodotyrosine coupling to form thyroxine.
Topics: Adolescent; Adult; Child; Child, Preschool; Diiodotyrosine; Female; Goiter; Humans; Iodine; Iodine I | 1971 |